Is avatrombopag currently included in medical insurance?

Avatrombopag, trade name "Sucoxin", is an oral small molecule thrombopoietin receptor agonist, mainly used to treat preoperative thrombocytopenia in patients with chronic liver disease, as well as chronic immune thrombocytopenia (ITP) and other indications. At present, the drug has been officially approved for marketing in China and has been successfully included in the national medical insurance directory, which has greatly reduced the financial burden on patients.

In the domestic market, avatrombopag is mainly available in two specifications, namely 20mg10 tablets and 20mg15 tablets. According to the latest pharmacy public information, the price of 10 tablets is about 5000 multiple RMB, 15packs range from 7000 to 8000 yuan. Since this drug has been included in medical insurance, the specific reimbursement ratio will vary by region. Therefore, it is recommended that patients consult the pharmacy or medical insurance office of the hospital where they are visiting before purchasing to learn about the latest local policies and the actual out-of-pocket amount after medical insurance.

In addition to the domestic version of the original drug, avatrombopag also has multiple generic versions circulating in overseas markets. Currently, a generic drug approved by the Lao health department is on the market. In addition, Bangladeshi pharmaceutical companies have also launched a generic version of the drug. These generic drugs are basically the same as the original drugs in terms of ingredients and dosage. They are drugs produced through legal and compliant channels and mainly meet the treatment needs of people with heavy economic burdens.

The prices of the Laotian and Bangladeshi versions of generic avatrombopag are more affordable than the domestic original drugs, with each box usually costing around a few hundred yuan. Although the price advantage of generic drugs is obvious, patients should still ensure that the source of the drug is formal when choosing. It is recommended to obtain it through formal medical channels or professional drug service platforms and use it under the guidance of a doctor to ensure the efficacy and safety of the drug.

Reference materials:https://go.drugbank.com/drugs/DB11995

xa0